丹麦对风险分层乳腺癌查的态度 - - 定性研究
Ann-Britt Kvernrød1, Christina Hilding Rasmussen2, Line Hjøllund Pedersen2,3
1Department of Prevention and Information, Danish Cancer Society, Strandboulevarden 49, 2100, Copenhagen, Denmark. abk@cancer.dk.
BMC cancer
|November 26, 2024
概括
丹麦妇女愿意根据个人风险进行个性化乳腺癌查,而不是基于年龄的计划. 在评估当前查的同时,他们认为量身定制的方法有好处,特别是在高风险人群中.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医学社会学 医学社会学
背景情况:
- 目前的乳腺癌查计划通常以年龄为基础.
- 针对乳腺癌查进行个性化风险评估是一个正在发展中的概念.
- 欧洲国家很可能在未来采用个性化查.
研究的目的:
- 探索丹麦妇女对乳腺癌风险的理解.
- 评估女性对风险分层乳腺癌查的态度.
主要方法:
- 定性研究涉及46名年龄在50-69岁的女性.
- 利用人类学方法与解释性描述.
- 通过半结构化焦点小组和电话采访收集的数据,使用系统文本凝聚分析.
主要成果:
- 妇女非常重视目前的乳房镜查,以早期检测.
- 参与者了解乳腺癌的原因,但没有深入考虑个人风险.
- 个性化查方法被认为比基于年龄的方法更可靠.
- 妇女承认,低风险并不意味着没有风险,高风险并不保证癌症.
- 尽管存在焦虑问题,但对高风险个体进行更频繁查的可能性表示赞赏.
结论:
- 丹麦妇女普遍接受乳腺癌查个人风险评分估计的概念.
- 对高风险妇女进行加强查可能比对低风险妇女进行减少查更可行.
- 需要进一步调查,以确认表达的兴趣是否转化为实际参与试验.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Longitudinal Research
11.9K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.9K
Actuarial Approach
63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63
Statistical Methods for Analyzing Epidemiological Data
305
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
305
Hazard Ratio
91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
91


